VALYSTR · Stock research
Listed on NasdaqGM. What the market is pricing into Ligand Pharmaceuticals Incorporated (LGND) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Pharmaceuticals · market value about $6.3B · P/E 141.7 · revenue $254M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows